Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| AU565 | BMS-265246 | 1.0 | 0.4538 | 0.06196 |
| AU565 | BMS-265246 | 1.0 | 0.3687 | 0.06313 |
| AU565 | BMS-265246 | 1.0 | 0.2400 | 0.05801 |
| AU565 | BMS-265246 | 3.16227766 | 0.1745 | 0.09266 |
| AU565 | BMS-265246 | 3.16227766 | 0.0306 | 0.12843 |
| AU565 | BMS-265246 | 3.16227766 | -0.0360 | 0.04422 |
| AU565 | BMS-265246 | 10.0 | -0.1891 | 0.16462 |
| AU565 | BMS-265246 | 10.0 | -0.1432 | 0.16723 |
| AU565 | BMS-265246 | 10.0 | -0.1392 | 0.10347 |
| AU565 | Ulixertinib | 0.001 | 1.1003 | -0.01282 |
| AU565 | Ulixertinib | 0.001 | 0.8736 | -0.00385 |
| AU565 | Ulixertinib | 0.001 | 1.2144 | -0.00992 |
| AU565 | Ulixertinib | 0.003162278 | 0.8153 | 0.01686 |
| AU565 | Ulixertinib | 0.003162278 | 1.1755 | -0.00123 |
| AU565 | Ulixertinib | 0.003162278 | 0.9572 | -0.02239 |
| AU565 | Ulixertinib | 0.01 | 0.9762 | 0.01474 |
| AU565 | Ulixertinib | 0.01 | 1.1480 | -0.00157 |
| AU565 | Ulixertinib | 0.01 | 0.9566 | -0.01811 |
| AU565 | Ulixertinib | 0.031622777 | 0.8791 | 0.00614 |
| AU565 | Ulixertinib | 0.031622777 | 0.9126 | -0.00036 |
| AU565 | Ulixertinib | 0.031622777 | 1.0676 | -0.01120 |
| AU565 | Ulixertinib | 0.1 | 1.0292 | 0.00949 |
| AU565 | Ulixertinib | 0.1 | 1.0554 | -0.01047 |
| AU565 | Ulixertinib | 0.1 | 1.0228 | 0.00037 |
| AU565 | Ulixertinib | 0.316227766 | 0.8956 | -0.00168 |